Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-21 · accession 0001968202-23-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-23 | 2023-08-22 | REGN | STAHL NEIL | EVP Research, Development | S - Sale+OE | $840.98 | -11.7K | 58.5K | -17% | -$9.81M |
| D | 2023-08-23 | 2023-08-21 | REGN | STAHL NEIL | EVP Research, Development | M - OptEx | $399.66 | +50.0K | 103.1K | +94% | +$19.98M |
| D | 2023-08-23 | 2023-08-21 | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $833.39 | -38.3K | 64.8K | -37% | -$31.95M |
| D | 2023-08-23 | 2023-08-21 | REGN | STAHL NEIL | EVP Research, Development | M - OptEx | $0.00 | -50.0K | 30.8K | -62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-22 | S | D | 782 | $842.16 | 53,100 | D | — | — | (F3) Represents volume-weighted average price of sales of 782 shares of Company stock on August 22, 2023 at prices ranging from $842.01 to $842.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-08-22 | S | D | 4,574 | $841.41 | 53,882 | D | — | — | (F2) Represents volume-weighted average price of sales of 4,574 shares of Company stock on August 22, 2023 at prices ranging from $841.01 to $841.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price. |
| 3 | Common | Common Stock | 2023-08-21 | M | A | 50,000 | $399.66 | 103,100 | D | — | — | |
| 4 | Common | Common Stock | 2023-08-21 | F | D | 38,335 | $833.39 | 64,765 | D | — | — | |
| 5 | Common | Common Stock | 2023-08-22 | S | D | 6,309 | $840.53 | 58,456 | D | — | — | (F1) Represents volume-weighted average price of sales of 6,309 shares of Company stock on August 22, 2023 at prices ranging from $840.00 to $840.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 22, 2023 at each separate price. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-08-21 | M | D | 50,000 | $0.00 | 30,750 | D | $399.66 · — to 2024-12-16 | 50,000 Common Stock | (F4) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |